Merck KGaA Selects Nippon Shinyaku as Japanese Partner For Alcohol Addiction Treatment
Merck KGaA today announced that it has entered into a Marketing, Distribution, Trademark and Supply Agreement with Nippon Shinyaku Co., Ltd. of Kyoto, Japan, for the Japanese rights to acamprosate (Campral®) in the treatment of alcohol dependence.
The agreement covers the development, marketing and promotion of acamprosate in Japan by Nippon Shinyaku. It includes milestone payments at key development stages as well as royalties on future sales by Nippon Shinyaku, along with an exclusive supply of acamprosate by Merck.
"Merck is very pleased to conclude this partnership agreement for acamprosate in Japan with Nippon Shinyaku," said Wilfried H. Meyer, Head of Merck KGaA's Established Products business.
Acamprosate has been approved in most major European markets for several years and is commercialized under the brand names Campral® and Aotal®. In addition, acamprosate is currently under registration in the US, and Merck will file an amendment to the New Drug Application with the U.S. Food and Drug Administration (FDA) later this year. "In this context, the collaboration with Nippon Shinyaku represents a key step in our global marketing strategy," Meyer added.
Most read news
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Film in 4-D with ultrashort electron pulses - Electron pulses shortened to 30 femtoseconds duration - giving insight to atomic motions

Lasers for hydrogen technology - Fraunhofer ILT inaugurates new research platform

How green cities could remove CO2 from the atmosphere - One gigatonne per year by mid-century: An study determines the potentials, various co-benefits and possible barriers to implementation

Graphene research: numerous products, no acute dangers - Successful completion of the EU Graphene Flagship
Reducing CO2 Emissions By Photochemical Recycling To Useful Chemicals - 1.18 Million Euro grant for development of heterogeneous photocatalysts

Towards a Greener Space Economy - ISPTech Secures €2M in Pre-Seed Funding for Innovative Spacecraft Propulsion Technology
Max Planck Innovation Concludes Licensing Agreement for Technology Providing Unlimited Resolution in Microscopy - Overcoming Abbe's law in light microscopy

Antilaser for Bose-Einstein condensate

Hawaiian scientists take their test tubes surfing
Evonik commences construction of methionine complex in Singapore
